Skip to content

Beneficient BENF Passthrough differences - temporary

Passthrough differences - temporary at other companies

Bicara Therapeutics logo
Bicara TherapeuticsBCAX
-0.5%
Trinity Capital logo
Trinity CapitalTRIN
-$5.13M
Kayne Anderson BDC logo
Kayne Anderson BDCKBDC
-$662K+8.9%
Capital Southwest logo
Capital SouthwestCSWC
-$2.1M+50.0%
REX American Resources logo
REX American ResourcesREX
$25.77M+245%
Blue Owl Capital logo
Blue Owl CapitalOBDC
-$20.1M-8.6%

Other financials

Income statement

See full
Revenue$18.7M+322%
Operating income$3.9M+141%
Net income$19.9M+331%
EPS (diluted)-$0.49+26.5%

Balance sheet

See full
Cash & equivalents$7.9M+87.3%
Total debt$100.3M-16.6%
Total equity-$128.6M-1,002%
Total assets$337.9M-15.5%

Cash flow

See full
Operating cash flow-$9.4M+6.3%
CapEx$96.0K-85.5%
Free cash flow-$9.4M+6.7%

Valuation

See full
Market cap$52.86M+2,018%
Enterprise value$145.33M+40.6%

Profitability

See full
Operating margin548.5%-323pp
Net margin517.9%-235pp
FCF margin156.8%-40.4pp

Returns & leverage

See full
Return on equity-1,647.1%-2,080pp
Debt / equity8.4×-23.8×

Where this comes from

Reported directly by Beneficient in its filing.

Tagged under the XBRL concept ben:DeferredTaxAssetsTemporaryPassthroughDifferences.

The official record: Beneficient’s 10-K, filed September 29, 2025, on SEC EDGAR. View the filing →

Ask your AI about Beneficient's passthrough differences - temporary.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Beneficient's passthrough differences - temporary?
Beneficient (BENF) reported passthrough differences - temporary of $30.11M in Q1 2025.
What is the long-term trend for Beneficient's passthrough differences - temporary?
Over 3 years (2022 to 2025), Beneficient's passthrough differences - temporary has grown at a 49.9% compound annual growth rate (CAGR), from $8.95M to $30.11M.
What does passthrough differences - temporary mean?
Represents the tax impact of temporary timing differences between the financial reporting and tax treatment of passthrough entities or investment structures. These assets arise when income or expenses are recognized in different periods for tax purposes compared to GAAP. Monitoring this metric helps investors understand future tax cash flow implications and the realization of deferred tax benefits.